Roivant Sciences ROIV Cash Flow Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| —— | -$318.93M-107% | $4.41B+496% | -$1.12B-20.7% | ||
| $3.35M-76.2% | $14.07M-36.1% | $22.04M+16.9% | $18.86M— | ||
| $346.17M+19.8% | $289.03M+44.8% | $199.63M-8.3% | $217.78M-61.5% | ||
| $3.42M— | —— | —— | —— | ||
| —— | —— | $40.15M+3.1% | $38.96M-23.0% | ||
| $7.42M-15.3% | $8.76M+153% | -$16.49M-195% | $17.42M— | ||
| -$1.01M-230% | $773K+132% | -$2.39M-211% | $2.15M— | ||
| —— | -$3.76M— | —— | —— | ||
| $85.05M+946% | -$10.05M-201% | $9.93M— | —— | ||
| —— | $55.19M— | —— | —— | ||
| $8.28M+20.9% | $6.84M0.0% | $6.85M-9.5% | $7.57M— | ||
| —— | -$8.85M— | —— | $0— | ||
| -$2.39M+58.2% | -$5.7M+31.5% | -$8.33M+3.2% | -$8.6M— | ||
| -$11.46M— | —— | $88.99M+181% | $31.67M— | ||
| -$750.35M+10.6% | -$839.45M-9.7% | -$765.27M+9.3% | -$843.39M-24.4% | ||
| —— | $4.6M+233% | $1.38M-89.1% | $12.69M-27.2% | ||
| —— | —— | $47.5M— | —— | ||
| $2.52M+3,287% | -$79K+99.1% | -$8.59M-1,124% | -$702K— | ||
| $0-100% | $4.06B— | $0— | —— | ||
| —— | —— | $5.2B— | —— | ||
| —— | $1.29B— | $0— | $0— | ||
| $0— | $0— | —— | $311.98M— | ||
| $0-100% | $774K-50.0% | $1.55M+124% | $692K— | ||
| —— | -$1.22B-370% | $451.99M-10.8% | $506.8M+60.8% | ||
| $3.77M— | —— | —— | $6.28M— | ||
| —— | —— | $4.99B— | —— | ||
| $0-100% | $5.96M-41.9% | $10.27M+93.6% | $5.3M-4.2% | ||
| —— | $69.96M— | —— | $0— | ||
| -$47.7M— | —— | -$85.38M— | —— | ||
| —— | $55.19M— | —— | —— | ||
| $0-100% | $110.39M— | —— | $0— | ||
| —— | $376.51M— | —— | $0— | ||
| $3.42M— | —— | —— | —— | ||
| $0— | $0-100% | $21.98M+18.3% | $18.57M— | ||
| $770.24M— | $0— | $0— | —— | ||
| -$2.39M+58.2% | -$5.7M+31.5% | -$8.33M+3.2% | -$8.6M— | ||
| -$11.46M— | —— | $88.99M+181% | $31.67M— | ||
| $15.59M— | —— | $0— | —— | ||
| $8.28M+20.9% | $6.84M0.0% | $6.85M-9.5% | $7.57M— | ||
| —— | -$3.76M+63.3% | -$10.25M-148% | $21.21M— | ||
| —— | —— | —— | —— | ||
| $2.52M+3,287% | -$79K+99.1% | -$8.59M-1,124% | -$702K— | ||
| $0-100% | $4.06B— | $0— | —— | ||
| $1.12B— | $0— | $0— | —— | ||
| —— | $110.39M-97.9% | $5.23B— | —— | ||
| $0-100% | $774K-50.0% | $1.55M+124% | $692K— | ||
| $48.62M+30.6% | $37.22M-1.3% | $37.72M+247% | $10.88M— | ||
| $193.61M— | —— | $238.73M— | —— | ||
| —— | —— | $0— | —— | ||
| —— | —— | $47.5M— | —— | ||
| —— | —— | —— | —— | ||
| $0-100% | $51.98M+78.3% | $29.16M-1.0% | $29.45M— | ||
| $0-100% | $11.65M— | $0— | $0— | ||
| —— | —— | -$441K— | —— | ||
| —— | —— | —— | $4.22M— | ||
| $57.69M— | —— | $0— | —— | ||
| $31.11M— | $0— | $0— | —— | ||
| -$758.56M+10.1% | -$844.05M-10.1% | -$766.65M+10.4% | -$856.08M-23.1% | ||
| -$758.56M+10.1% | -$844.05M-10.1% | -$766.65M+10.4% | -$856.08M-23.1% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Roivant Sciences generate?
- Roivant Sciences (ROIV) generated -$750.3M in operating cash flow over the trailing twelve months.
- What is Roivant Sciences's free cash flow?
- After $14.0M of capital expenditures, Roivant Sciences's free cash flow was -$758.6M over the trailing twelve months, up 10.1% year over year.
- Where does Roivant Sciences's cash flow data come from?
- Every line is extracted from Roivant Sciences's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
